Efficacy of lenalidomide in multiple myeloma and myelodysplastic syndrome with deletion of 5q in a patient with pre-existing MGUS

被引：0
|
作者：
Mueller, N. Z. [1 ]
Nolte, F. [1 ]
Kreil, S. [1 ]
Hofmann, W-K [1 ]
Metzgeroth, G. [1 ]
机构：
[1] Univ Med Mannheim, Med Klin 3, Mannheim, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：149 / 150
页数：2
相关论文
共 50 条
  • [31] Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?
    Duerr, Donat
    Siciliano, Raffaele Daniele
    Hummel, Yvonne
    O'Meara, Alix
    Hirschi, Anita
    Burkhard, Roger
    Honegger, Hanspeter
    ANNALS OF HEMATOLOGY, 2010, 89 (01) : 105 - 106
  • [32] Mechanisms of Resistance to Lenalidomide in Del(5q) Myelodysplastic Syndrome Patients
    Martinez-Hoyer, Sergio
    Docking, Rod
    Chan, Simon
    Jadersten, Martin
    Parker, Jeremy
    Karsan, Aly
    BLOOD, 2015, 126 (23)
  • [33] A decade of progress in myelodysplastic syndrome with chromosome 5q deletion
    List, Alan
    Ebert, Benjamin L.
    Fenaux, Pierre
    LEUKEMIA, 2018, 32 (07) : 1493 - 1499
  • [34] Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion
    Jadersten, Martin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 348 - 351
  • [35] EFFICACY AND SAFETY OF THE USE OF LENALIDOMIDE IN PATIENTS SUFFERING FROM MYELODYSPLASTIC SYNDROME WITHOUT DELETION OF 5Q DATA OF THE SPANISH REGISTRY OF SMD
    Sanchez Garcia, J.
    Diez Campelo, M.
    Ramos, F.
    Andreu, R.
    Santiago, O.
    Josefina, S.
    Javier, C.
    Sanz, G.
    HAEMATOLOGICA, 2015, 100 : 22 - 22
  • [36] ANALYSIS OF SHORT-TERM EFFICACY OF LENALIDOMIDE IN PATIENTS WITH INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROME WITHOUT 5Q DELETION
    Yang, Y.
    HAEMATOLOGICA, 2012, 97 : 582 - 582
  • [37] Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion
    Cannella, Laura
    Latagliata, Roberto
    Breccia, Massimo
    Carmosino, Ida
    Loglisci, Giuseppina
    Volpicelli, Paola
    Ferretti, Antonietta
    Santopietro, Michelina
    Vozella, Federico
    Girmenia, Corrado
    Cuzzola, Mariella
    Oliva, Esther Natalie
    Alimena, Giuliana
    ANNALS OF HEMATOLOGY, 2012, 91 (02) : 309 - 310
  • [38] Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion
    Laura Cannella
    Roberto Latagliata
    Massimo Breccia
    Ida Carmosino
    Giuseppina Loglisci
    Paola Volpicelli
    Antonietta Ferretti
    Michelina Santopietro
    Federico Vozella
    Corrado Girmenia
    Mariella Cuzzola
    Esther Natalie Oliva
    Giuliana Alimena
    Annals of Hematology, 2012, 91 : 309 - 310
  • [39] 5q duplication and 13q deletion in a patient with Fanconi anemia associated with Myelodysplastic syndrome
    Bennour, H. Sennana
    Omri, H. E. L.
    Khelif, A.
    Saad, A.
    CHROMOSOME RESEARCH, 2007, 15 : 218 - 219
  • [40] Short Telomeres Before Lenalidomide Treatment Predict Leukemic Progression In Patients with Myelodysplastic Syndrome and Deletion 5q
    Gohring, Gudrun
    Lange, Kathrin
    Hofmann, Winfried
    Nielsen, Kirsten Vang
    Hellstrom-Lindberg, Eva
    Roy, Lydia
    Morgan, Michael
    Kreipe, Hans
    Buesche, Guntram
    Giagounidis, Aristoteles
    Schlegelberger, Brigitte
    BLOOD, 2010, 116 (21) : 18 - 18
12345